Epizyme Inc. diskutieren
Epizyme Inc.
WKN: A1T9L2 / Symbol: EPZM / Name: Epizyme / Aktie / Biotechnologie & medizinische Forschung / Small Cap /
folgen
a +
Gesundheit | Biotechnologie | Vereinigte Staaten
$$
$ EPZM PT raiste auf $ 27 von $ 21 bei Suntrust
a +
stratec stimmt dem Sentiment von 'Buy' zu
Oppenheimer's call:An annoncement of the partial clinical hold being lifted by FDA supports our outlook for tazemetostat. Tazemetostat is currently being studied in clinical programs in INI-1 negative tumors, synovial sarcomas, follicular lymphoma, diffuse large B-cell lymphoma (DLBCL), and mesothelioma. While the partial clinical hold may have delayed enrollment in some studies, these are not currently factored into our outlook; therefore, the hold had little impact on our outlook. The news removes a regulatory overhang and supports our outlook for Epizyme.”
Neueste Beiträge
robertinio in Boss Energy Ltd. diskutieren